You just read:

Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells

News provided by

Rock Creek Pharmaceuticals, Inc.

Jul 01, 2015, 08:30 ET